Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
Research context
Shenzhen Neptunus Bioengineering Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Shenzhen Neptunus Bioengineering Co., Ltd is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Shenzhen Neptunus Bioengineering Co., Ltd's total revenue rose by 10.4% to $11B since the same quarter in the previous year.
Its net income has dropped by 55.4% to $72M since the same quarter in the previous year.
Finally, its free cash flow fell by 6411.4% to $-616M since the same quarter in the previous year.
Based on the above factors, Shenzhen Neptunus Bioengineering Co., Ltd gets an overall score of 2/5.